Normalized LST is an efficient biomarker for homologous recombination deficiency and Olaparib response in ovarian carcinoma

Yann Christinat, Liza Ho, Sophie Clément, Catherine Genestie, Jalid Sehouli, Antonio Gonzalez Martin, Ursula Denison, Keiichi Fujiwara, Ignace Vergote, Germana Tognon, Sakari Hietanen, Isabelle Ray-Coquard, Eric Pujade-Lauraine, Thomas A. McKee
doi: https://doi.org/10.1101/2022.08.22.22278669

Article usage

Article usage: August 2022 to January 2025

AbstractFullPdf
Aug 20223831367
Sep 202229620122
Oct 2022170970
Nov 20221584672
Dec 20221011439
Jan 2023571936
Feb 202379933
Mar 2023881841
Apr 2023451116
May 2023421912
Jun 2023421549
Jul 2023511912
Aug 2023393218
Sep 202345114
Oct 2023301810
Nov 2023321716
Dec 202318817
Jan 202418118
Feb 202415196
Mar 202413106
Apr 2024291520
May 202415630
Jun 2024331910
Jul 202417812
Aug 20241534
Sep 202425715
Oct 20241179
Nov 202413211
Dec 20242135
Jan 2025312
Back to top
Posted August 23, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Normalized LST is an efficient biomarker for homologous recombination deficiency and Olaparib response in ovarian carcinoma
Yann Christinat, Liza Ho, Sophie Clément, Catherine Genestie, Jalid Sehouli, Antonio Gonzalez Martin, Ursula Denison, Keiichi Fujiwara, Ignace Vergote, Germana Tognon, Sakari Hietanen, Isabelle Ray-Coquard, Eric Pujade-Lauraine, Thomas A. McKee
medRxiv 2022.08.22.22278669; doi: https://doi.org/10.1101/2022.08.22.22278669
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area